Jonathan M Peacock Insider Trading $AMGN AMGEN INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jonathan M Peacock.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jonathan M Peacock. Jonathan M Peacock is CFO in AMGEN INC ($AMGN) and EVP & CFO in AMGEN INC ($AMGN) and Director in Kite Pharma, Inc. ($KITE) and in Bellerophon Therapeutics, Inc. ($BLPH) and Director in Bellerophon Therapeutics, Inc. ($BLPH) and President and CEO in Bellerophon Therapeutics, Inc. ($BLPH) and Director in Avantor, Inc. ($AVTR).
Jonathan M Peacock in AMGEN INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jonathan M Peacock: EVP & CFO, CFO
Holdings: 94,414 shares
Current Value: $15,750,143
Latest Transaction: Oct 29 2013
$AMGN Market Capitalization: $124.07B
$AMGN Previous Close: $166.82
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jonathan M Peacock in AMGEN INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMGN, AVTR, BLPH, KITE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 29 2013 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Payment of Exercise | F | 116.32 | 13,045 | 1,517,394 | 94,414 | 107.5 K to 94.4 K (-12.14 %) |
| Apr 29 2013 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Payment of Exercise | F | 104.93 | 2,721 | 285,515 | 107,312 | 110 K to 107.3 K (-2.47 %) |
| Jan 30 2013 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Grant | A | 0.00 | 7,477 | 0 | 109,950 | 102.5 K to 110 K (+7.30 %) |
| Oct 29 2012 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Payment of Exercise | F | 87.63 | 11,671 | 1,022,730 | 102,438 | 114.1 K to 102.4 K (-10.23 %) |
| May 01 2012 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Grant | A | 0.00 | 8,654 | 0 | 114,027 | 105.4 K to 114 K (+8.21 %) |
| Oct 31 2011 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Payment of Exercise | F | 58.06 | 10,427 | 605,392 | 105,373 | 115.8 K to 105.4 K (-9.00 %) |
| Apr 27 2011 | AMGN | AMGEN INC | Peacock Jonathan M | CFO | Option Exercise | A | 54.69 | 55,125 | 3,014,786 | 55,125 | |
| Apr 27 2011 | AMGN | AMGEN INC | Peacock Jonathan M | CFO | Grant | A | 0.00 | 15,800 | 0 | 115,800 | 100 K to 115.8 K (+15.80 %) |
| Oct 29 2010 | AMGN | AMGEN INC | Peacock Jonathan M | CFO | Option Exercise | A | 57.27 | 175,000 | 10,022,250 | 175,000 | |
| Oct 29 2010 | AMGN | AMGEN INC | Peacock Jonathan M | CFO | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Page: 1